个性化文献订阅>文章检索
  文章名  
  作者  
  期刊名  
  摘要  
   
   
   
  如果没有找到您所需要的文献,请点击 ——此处申请  
  共18条记录  
  • Ribonuclease-Activated Cancer Prodrug
    [作者:ELLIS GREGORY A; MCGRATH NICHOLAS A; PALTE MICHAEL J; RAINES RONALD T,期刊:ACS Medicinal Chemistry Letters, 页码:268-272 , 文章类型: Article,,卷期:2012年3-4]
  • Cancer chemotherapeutic agents often have a narrow therapeutic index that challenges the maintenance of a safe and effective dose. Consistent plasma concentrations of a drug can be obtained by using a timed-release prodr...
  • Avicholic Acid: A Lead Compound from Birds on the Route to Potent TGR5 Modulators
    [作者:PELLICCIARI ROBERTO; GIOIELLO ANTIMO; SABBATINI PAOLA; VENTURONI FRANCESCO; NUTI ROBERTO; COLLIVA CAROLINA; RIZZO GIOVANNI; ADORINI LUCIANO; PRUZANSKI MARK; RODA ALDO; MACCHIARULO ANTONIO,期刊:ACS Medicinal Chemistry Letters, 页码:273-277 , 文章类型: Article,,卷期:2012年3-4]
  • Grounding on our former 3D QSAR studies, a knowledge-based screen of natural bile acids from diverse animal species has led to the identification of avicholic acid as a selective but weak TGRS agonist. Chemical modificat...
  • Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization
    [作者:DOWLING JAMES E; CHUAQUI CLAUDIO; PONTZ TIMOTHY W; LYNE PAUL D; LARSEN NICHOLAS A; BLOCK MICHAEL H; CHEN HUAWEI; SU NANCY; WU ALLAN; RUSSELL DANIEL; POLLARD HANNAH; LEE JOHN W; PENG BO; THAKUR KUMAR; YE QING; ZHANG TAO; BRASSIL PATRICK; RACICOT VICKI; BAO LARRY; DENZ CHRISTOPHER R; COOKE EMMA,期刊:ACS Medicinal Chemistry Letters, 页码:278-283 , 文章类型: Article,,卷期:2012年3-4]
  • In this paper we describe a series of 3-cyano-5-aryl-7-aminopyrazolo[1,5-a]-pyrimidine hits identified by kinase-focused subset screening as starting points for the structure-based design of conformationally constrained ...
  • Stimulation of Glucose-Dependent Insulin Secretion by a Potent, Selective sst(3) Antagonist
    [作者:PASTERNAK ALEXANDER; FENG ZHE; DE JESUS REYNALDA; YE ZHIXIONG; HE SHUWEN; DOBBELAAR PETER; BRADLEY SCOTT A; CHICCHI GARY G; TSAO KWEILAN; TRUSCA DORINA; EIERMANN GEORGE J; LI CAI; FENG YUE; WU MARGARET; SHAO QING; ZHANG BEI B; NARGUND RAVI; MILLS SANDER G; HOWARD ANDREW D; YANG LIHU; ZHOU YUNPING,期刊:ACS Medicinal Chemistry Letters, 页码:289-293 , 文章类型: Article,,卷期:2012年3-4]
  • This letter provides the first pharmacological proof of principle that the sst(3) receptor mediates glucose-stimulated insulin secretion (GSIS) from pancreatic beta-cells. To enable these studies, we identified the selec...
  • Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor
    [作者:HARPER STEVEN; MCCAULEY JOHN A; RUDD MICHAEL T; FERRARA MARCO; DIFILIPPO MARCELLO; CRESCENZI BENEDETTA; KOCH UWE; PETROCCHI ALESSIA; HOLLOWAY M KATHARINE; BUTCHER JOHN W; ROMANO JOSEPH J; BUSH KIMBERLY J; GILBERT KEVIN F; MCINTYRE CHARLES J; NGUYEN KEVIN T; NIZI EMANUELA; CARROLL STEVEN S; LUDMERER STEVEN W; BURLEIN CHRISTINE; DIMUZIO JILLIAN M; GRAHAM DONALD J; MCHALE CAROLYN M; STAHLHUT MARK W; OLSEN DAVID B; MONTEAGUDO EDITH; CIANETTI SIMONA; GIULIANO CLAUDIO; PUCCI VINCENZO; TRAINOR NICOLE; FANDOZZI CHRISTINE M; ROWLEY MICHAEL; COLEMAN PAUL J; VACCA JOSEPH P; SUMMA VINCENZO; LIVERTON NIGEL J,期刊:ACS Medicinal Chemistry Letters, 页码:332-336 , 文章类型: Article,,卷期:2012年3-4]
  • A new class of HCV NS3/4a protease inhibitors containing a P2 to P4 macrocyclic constraint was designed using a molecular modeling-derived strategy. Building on the profile of previous clinical compounds and exploring th...